These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38499825)

  • 1. Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry.
    Aksu T; Tung R; De Potter T; Markman TM; Santangeli P; du Fay de Lavallaz J; Winterfield JR; Baykaner T; Alyesh D; Joza JE; Gopinathannair R; Badertscher P; Do DH; Hussein A; Osorio J; Dewland T; Perino A; Rodgers AJ; DeSimone C; Alfie A; Atwater BD; Singh D; Kumar K; Salcedo J; Bradfield JS; Upadhyay G; Sood N; Sharma PS; Gautam S; Kumar V; Forno ARJD; Woods CE; Rav-Acha M; Valeriano C; Kapur S; Enriquez A; Sundaram S; Glikson M; Gerstenfeld E; Piccini J; Tzou WS; Sauer W; d'Avila A; Shivkumar K; Huang HD
    J Interv Card Electrophysiol; 2024 Mar; ():. PubMed ID: 38499825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial.
    Piotrowski R; Baran J; Sikorska A; Krynski T; Kulakowski P
    JACC Clin Electrophysiol; 2023 Jan; 9(1):85-95. PubMed ID: 36114133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia: Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs-The ELEGANCE multicenter study.
    Francia P; Viveros D; Falasconi G; Penela D; Soto-Iglesias D; Martí-Almor J; Alderete J; Saglietto A; Bellido AF; Franco-Ocaña P; Zaraket F; Matiello M; Fernández-Armenta J; San Antonio R; Berruezo A
    Heart Rhythm; 2023 Sep; 20(9):1279-1286. PubMed ID: 37329936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioneuroablation for Cardioinhibitory Vasovagal Syncope: Rationale, Approaches, and Its Role in Long-Term Management.
    Aksu T; Chung MK
    Curr Cardiovasc Risk Rep; 2024 Apr; 18(4):55-64. PubMed ID: 38707611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: An international clinician survey.
    Vandenberk B; Morillo CA; Sheldon RS; Chew DS; Aksu T; Raj SR
    Heart Rhythm; 2021 Dec; 18(12):2160-2166. PubMed ID: 34419666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioneuroablation in the Management of Vasovagal Syncope, Sinus Node Dysfunction and Functional Atrioventricular Block: Patient Selection Based on Supporting Evidence.
    Aksu T; Erdem Guler T
    J Atr Fibrillation; 2020; 13(1):2396. PubMed ID: 33024497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioneuroablation for Treating Vasovagal Syncope: Current Status and Future Directions.
    Li L; Po S; Yao Y
    Arrhythm Electrophysiol Rev; 2023; 12():e18. PubMed ID: 37457436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioneuroablation for the Treatment of Vasovagal Syncope: Current Status and Impact on Quality of Life.
    Traykov V; Shalganov T
    Curr Cardiol Rep; 2023 Dec; 25(12):1839-1849. PubMed ID: 37982935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioneuroablation for cardioinhibitory vasovagal syncope.
    John LA; Mullis A; Payne J; Tung R; Aksu T; Winterfield JR
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1748-1753. PubMed ID: 33855779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioneuroablation for severe neurocardiogenic syncope.
    Santos Silva G; Fonseca P; Cardoso F; Almeida J; Ribeiro S; Oliveira M; Sanfins V; Gonçalves H; Pachon M JC; Barra S; Primo J; Lourenço A; Fontes-Carvalho R
    Rev Port Cardiol; 2023 Oct; 42(10):821-829. PubMed ID: 37268266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefit of cardioneuroablation to reduce syncope recurrence in vasovagal syncope patients: a case-control study.
    Aksu T; Padmanabhan D; Shenthar J; Yalin K; Gautam S; Valappil SP; Banavalikar B; Guler TE; Bozyel S; Tanboga IH; Lakkireddy D; Olshansky RB; Gopinathannair R
    J Interv Card Electrophysiol; 2022 Jan; 63(1):77-86. PubMed ID: 33527216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent pacing versus cardioneuroablation for cardioinhibitory vasovagal syncope.
    Gopinathannair R; Olshansky B; Turagam MK; Gautam S; Futyma P; Akella K; Tanboga HI; Bozyel S; Yalin K; Padmanabhan D; Shenthar J; Lakkireddy D; Aksu T
    J Interv Card Electrophysiol; 2022 Dec; ():. PubMed ID: 36562915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioneuroablation as a strategy to prevent pacemaker implantation in young patients with vasovagal syncope.
    Joza J; Gustavo Bravosi da Rosa L; Alturki A; Anglesio V; Sanchez-Somonte P; Poletaev V; Bernier M; Verma A; Essebag V
    Int J Cardiol Heart Vasc; 2024 Apr; 51():101360. PubMed ID: 38379634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioneuroablation for vasovagal syncope: insights on patients' selection, centre settings, procedural workflow and endpoints-results from an European Heart Rhythm Association survey.
    Penela D; Berruezo A; Roten L; Futyma P; Richter S; Falasconi G; Providencia R; Chun J
    Europace; 2024 May; 26(5):. PubMed ID: 38781099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of cardioneuroablation in different subtypes of vasovagal syncope.
    Tu B; Lai ZH; Chen AY; Weng ZY; Cai SM; Zhang ZX; Zhou LK; Zheng LH; Yao Y
    J Geriatr Cardiol; 2024 Jun; 21(6):651-657. PubMed ID: 38973824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential consequences of cardioneuroablation for vasovagal syncope: A call for appropriately designed, sham-controlled clinical trials.
    Chakraborty P; Chen PS; Gollob MH; Olshansky B; Po SS
    Heart Rhythm; 2024 Apr; 21(4):464-470. PubMed ID: 38104955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope.
    Tu B; Wu L; Hu F; Fan S; Liu S; Liu L; Ding L; Zheng L; Yao Y
    Heart Rhythm; 2022 Apr; 19(4):562-569. PubMed ID: 34896621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation.
    Aksu T; Guler TE; Bozyel S; Yalin K; Gopinathannair R
    Europace; 2020 Sep; 22(9):1320-1327. PubMed ID: 32898255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of cardioneuroablation with and without extra-cardiac vagal stimulation confirmation in severe cardioinhibitory neurocardiogenic syncope.
    Pachon-M JC; Pachon-M EI; Pachon CTC; Santillana-P TG; Lobo TJ; Pachon-M JC; Higuti C; Zerpa-A JC; Pachon MZC; Ortencio FA; Osorio TG; Peixoto LA
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):641-650. PubMed ID: 38240356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionation Mapping of the Ganglionated Plexi for Cardioneuroablation.
    John LA; Mullis A; Payne J; Tung R; Aksu T; Winterfield JR
    J Innov Card Rhythm Manag; 2021 Apr; 12(4):4473-4476. PubMed ID: 33936863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.